Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Molecular landscape of myelodysplastic/myeloproliferative neoplasms revealed

Molecular landscape of myelodysplastic/myeloproliferative neoplasms revealed

Engineered T-cells attack solid-tumor cancer cells from humans and mice

Engineered T-cells attack solid-tumor cancer cells from humans and mice

A metabolic enzyme could be a potential drug target for B cell lymphomas

A metabolic enzyme could be a potential drug target for B cell lymphomas

CAR T Cell Therapy: Potential For Considerable Savings

CAR T Cell Therapy: Potential For Considerable Savings

Developments in Engineered T Cells for Type 1 Diabetes

Developments in Engineered T Cells for Type 1 Diabetes

Deleting a key gene to create an immune cell with stronger anti-tumor activity

Deleting a key gene to create an immune cell with stronger anti-tumor activity

Researchers identify key gene essential for leukemia stem cells' survival

Researchers identify key gene essential for leukemia stem cells' survival

A New Tool To Map The Flow Of Info Within Living Cells

A New Tool To Map The Flow Of Info Within Living Cells

Mouse model helps track organism’s development, cell by cell

Mouse model helps track organism’s development, cell by cell

Treating solid cancers using the formation of natural killer-tumor cell immunological synapse

Treating solid cancers using the formation of natural killer-tumor cell immunological synapse

Research uncovers a novel mechanism for controlling genes

Research uncovers a novel mechanism for controlling genes

Selectively eliminating leukemic and hematopoietic stem cells

Selectively eliminating leukemic and hematopoietic stem cells

MSC‐induced Treg population can yield abundant replacement for naturally occurring T-cells

MSC‐induced Treg population can yield abundant replacement for naturally occurring T-cells

Immune System Changes Occur Early In Development Of Multiple Myeloma

Immune System Changes Occur Early In Development Of Multiple Myeloma

Researchers use genome-wide CRISPR technology to identify leukemia's weakness

Researchers use genome-wide CRISPR technology to identify leukemia's weakness

Study explores the impact of solute carriers on the activity and potency of cytotoxic drugs

Study explores the impact of solute carriers on the activity and potency of cytotoxic drugs

A new study finds a potential immunotherapeutic pan-target on cancer cells

A new study finds a potential immunotherapeutic pan-target on cancer cells